Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Lexagene Holdings Inc (LXG) NPV

Sell:0.69 CAD Buy:0.71 CAD Change: 0.01 CAD (1.41%)
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
Sell:0.69 CAD
Buy:0.71 CAD
Change: 0.01 CAD (1.41%)
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
Sell:0.69 CAD
Buy:0.71 CAD
Change: 0.01 CAD (1.41%)
Market closed |  Prices as at close on 24 January 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LexaGene Holdings Inc, formerly Wolfeye Resource Corp, is a Canada-based biotechnology company. The Company focuses on building automated instruments for rapid pathogen detection. The Company's instrument operates a layperson, allowing the Company to place these instruments at the site of collection, whether inside of food processing plants or inside hospitals.

Contact details

Address:
500 Cummings Ctr Ste 4550
BEVERLY
01915-6534
United States
Telephone:
+1 (604) 6810084
Website:
lexagene.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LXG
ISIN:
CA52886L1031
Market cap:
62.91 million CAD
Shares in issue:
85.74 million
Sector:
Health Care Equipment
Exchange:
Canadian Venture Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • John Regan
    Chairman of the Board, Chief Executive Officer
  • Daryl Rebeck
    President, Director
  • Jeffrey Mitchell
    Chief Financial Officer
  • Greg Dale
    Vice President - Product Development and Manufacturing
  • Allan Fabbro
    Vice President - Corporate Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.